mesalamine has been researched along with Dyslipidemia in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 1 |
| Koonen, D | 1 |
| Hofker, M | 1 |
| Bao, Z | 1 |
1 other study available for mesalamine and Dyslipidemia
| Article | Year |
|---|---|
5-aminosalicylic acid improves lipid profile in mice fed a high-fat cholesterol diet through its dual effects on intestinal PPARĪ³ and PPARĪ±.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cholesterol, Dietary; Diet, High-Fat; Dyslipidemia | 2018 |